- Home
- MIRA vs ADXN Comparison
MIRA vs ADXN Comparison
Compare MIRA & ADXN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- MIRA
- ADXN
- Stock Information
- Founded
- MIRA 2020
- ADXN 2002
- Country
- MIRA United States
- ADXN Switzerland
- Employees
- MIRA N/A
- ADXN N/A
- Industry
- MIRA Biotechnology: Pharmaceutical Preparations
- ADXN Biotechnology: Pharmaceutical Preparations
- Sector
- MIRA Health Care
- ADXN Health Care
- Exchange
- MIRA Nasdaq
- ADXN Nasdaq
- Market Cap
- MIRA 17.1M
- ADXN 11.3M
- IPO Year
- MIRA 2023
- ADXN N/A
- Fundamental
- Price
- MIRA $1.05
- ADXN $11.26
- Analyst Decision
- MIRA Strong Buy
- ADXN Strong Buy
- Analyst Count
- MIRA 2
- ADXN 1
- Target Price
- MIRA $14.00
- ADXN $30.00
- AVG Volume (30 Days)
- MIRA 552.1K
- ADXN 24.7K
- Earning Date
- MIRA 11-11-2024
- ADXN 11-11-2024
- Dividend Yield
- MIRA N/A
- ADXN N/A
- EPS Growth
- MIRA N/A
- ADXN N/A
- EPS
- MIRA N/A
- ADXN 0.05
- Revenue
- MIRA N/A
- ADXN $960,641.00
- Revenue This Year
- MIRA N/A
- ADXN N/A
- Revenue Next Year
- MIRA N/A
- ADXN N/A
- P/E Ratio
- MIRA N/A
- ADXN $1.87
- Revenue Growth
- MIRA N/A
- ADXN N/A
- 52 Week Low
- MIRA $0.51
- ADXN $5.00
- 52 Week High
- MIRA $6.40
- ADXN $27.90
- Technical
- Relative Strength Index (RSI)
- MIRA 38.97
- ADXN 64.36
- Support Level
- MIRA $1.04
- ADXN $10.04
- Resistance Level
- MIRA $1.20
- ADXN $10.81
- Average True Range (ATR)
- MIRA 0.07
- ADXN 0.63
- MACD
- MIRA 0.02
- ADXN 0.08
- Stochastic Oscillator
- MIRA 19.44
- ADXN 86.17
About MIRA MIRA Pharmaceuticals Inc.
Mira Pharmaceuticals Inc is a pre-clinical-stage pharmaceutical development company with two neuroscience programs targeting a broad range of neurologic and neuropsychiatric disorders. The company's novel oral pharmaceutical marijuana, MIRA-55, is under investigation for treating adult patients suffering from anxiety and cognitive decline, often associated with early-stage dementia.
About ADXN Addex Therapeutics Ltd
Addex Therapeutics Ltd is a clinical stage biopharmaceutical company. The company is focused on the development and commercialization of an emerging class of novel orally available small-molecule drugs known as allosteric modulators. The company's geographical area of operations includes Switzerland and Europe. The Company operates in one segment which is the discovery, development and commercialization of small-molecule pharmaceutical products.